Atria Oyj Class A · OMXHEX:ATRAV
Atria Oyj Class A — Q3 2026 Earnings Presentation
15 slides from Atria Oyj Class A's earnings presentation, Oct 22, 2026
Slide 1: Atria Plc Interim Report Q3/2026
22.10.2026 ATRIA PLC INTERIM REPORT Q3/2026 1 January – 30 September 2026 1 ATRIA CONTINUED TO GROW PROFITABLY IN AN UNCERTAIN OPERATING ENVIRONMENT Atria has continued the Atria Group's profitable growth determined implementation of its continued in January–September TOGETHER 2030 strategy. Future
Slide 2: After the review period; Q3/2026 result development in figures
22.10.2026 AFTER THE REVIEW PERIOD • Atria has completed the change negotiations concerning the Jyväskylä cattle slaughterhouse. • Atria is centralising its cattle slaughtering operations at the Kauhajoki plant and discontinuing cattle slaughtering in Jyväskylä. The decision to transfer the cutting
Slide 3: Q1-Q3/2026 result development in figures
22.10.2026 Q1-Q3/2026 RESULT DEVELOPMENT IN FIGURES 1,406.6 +5.2% Net sales, Net sales development 59.9 EBIT, EUR million 4.3% EBIT % EUR million (EUR 55.9 million) (4.2%) 1.49 Earnings per share, EUR -10.6 Free cash flow, 11.7% 43.9% Adjusted return of equity %, Equity ratio (EUR 1.30) EUR million
Slide 4: Atria Group's net sales Q1-Q3/2026 and EBIT Q3/2026
22.10.2026 ATRIA GROUP’S NET SALES Q1-Q3/2026 EUR million 7 ATRIA GROUP’S EBIT Q3/2026 EUR million 8 4
Slide 5: Market position in the business areas
22.10.2026 ATRIA GROUP’S EBIT Q1-Q3/2026 EUR million 9 MARKET POSITION IN THE BUSINESS AREAS • The development of Atria's product categories in the retail market by value in January-August: • Finland +4.7% • Sweden +2.7% • Estonia +3.8% • Denmark +0.5% • Atria's own brand producer share by value in
Slide 6: Atria Finland
22.10.2026 ATRIA FINLAND Q3/2026 Key Figures Q1-Q3/2026 Key Figures 341.8 +3.4% 1,024.0 +5.8% Net sales, Net sales development Net sales, Net sales development EUR million EUR million 19.4 -2.4 48.0 -0.6 EBIT, EBIT development, EBIT, EBIT development, EUR million EUR million EUR million EUR million
Slide 7: ASF in Finland
22.10.2026 ASF IN FINLAND • African swine fever (ASF) has been found in wild boar in a restricted area in south-eastern Finland. • ASF is a serious viral disease of pigs and other suids. The disease is not transmissible to humans. • To prevent the spread of the disease, the Finnish Food Authority ha
Slide 8: Atria Finland; Atria Sweden
22.10.2026 ATRIA FINLAND • In the summer of 2026, Atria launched an investment in a 200 MWh high-temperature energy storage at the Nurmo production plant as part of the energy solutions for the new convenience food factory under construction. • Atria’s new convenience food factory and the Kauhajoki
Slide 9: Atria Sweden
22.10.2026 ATRIA SWEDEN • In July–September, net sales grew by 8.3% from the comparison period. The growth in net sales was driven by good sales development across all sales channels. • EBIT increased by EUR 2.4 million. Effective sales and marketing measures, along with a favourable sales mix, bols
Slide 10: Atria Denmark & Estonia
22.10.2026 ATRIA DENMARK & ESTONIA Q3/2026 Key Figures Q1-Q3/2026 Key Figures 31.7 Net sales, -3.2% Net sales development 91.7 Net sales, -2.5% Net sales development EUR million EUR million 1.7 +0.3 5.9 +1.2 EBIT development, EBIT, EBIT development, EBIT, EUR million EUR million EUR million EUR mill
Slide 11: Atria Denmark & Estonia; Short-term business risks
22.10.2026 ATRIA DENMARK & ESTONIA • During the review period, the Maks & Moorits brand expanded into a new product category with a launch of antibiotic-free fresh chicken products made by Atria Finland. • Atria Denmark’s development efforts focused in particular on expanding the Foodservice product
Slide 12: Financial development
22.10.2026 FINANCIAL DEVELOPMENT ”We can be satisfied with the strong growth and solid year-to-date result, especially considering the immediate impact of the African swine fever outbreak detected in Finland at the end of July on Atria Finland’s exports, as well as the increased cost pressures cause
Slide 13: Atria Group adjusted EBIT cumulative; income statement
22.10.2026 ATRIA GROUP ADJUSTED EBIT CUMULATIVE EUR million 25 ATRIA GROUP INCOME STATEMENT Q3 Q3 Q1-Q3 Q1-Q3 EUR million 2026 2025 2026 2025 2025 NET SALES 475.2 457.0 1,406.6 1,337.2 1,813.7 Costs of goods sold -418.6 -403.6 -1,247.9 -1,189.3 -1,615.8 GROSS PROFIT 56.6 53.4 158.8 148.0 198.0 % of
Slide 14: Group key indicators; financial position and equity ratio
22.10.2026 ATRIA GROUP KEY INDICATORS Q3 Q3 Q1-Q3 Q1-Q3 EUR million 2026 2025 2026 2025 2025 Net sales 475.2 457.0 1,406.6 1,337.2 1,813.7 Adjusted EBIT 25.3 25.4 59.9 55.9 69.9 Adjusted EBIT, % 5.3 % 5.6 % 4.3 % 4.2 % 3.9 % EBIT 25.3 25.4 59.9 55.9 64.0 EBIT, % 5.3 % 5.6 % 4.3 % 4.2 % 3.5 % EPS, EU
Slide 15: Thank you!
22.10.2026 ATRIA CONTINUED TO GROW PROFITABLY IN AN UNCERTAIN OPERATING ENVIRONMENT Atria has continued the Atria Group's profitable growth determined implementation of its continued in January–September TOGETHER 2030 strategy. Future outlook The Group’s net sales was 4.0% • Atria continued the im